ICON Discusses How AI is Changing Clinical Trial Recruitment and Diversity
In this discussion with Kathleen Mandziuk, Vice President of eClinical Development & Delivery at ICON, we explore the dynamic...
Moe Alsumidaie
Where is RBQM Heading in The Future With AI?
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials....
Advancing Cancer Care: The Impact of Illinois’ New Bill of Rights
In this interview, we conversed with Pete Govorchin, President, City of Hope® Cancer Center Chicago and Edward S. Kim,...
Transforming Clinical Trial Dropout Through Patient Psychology
In this conversation with Dominique Demolle, CEO of Cognivia, we explore the power of understanding patient psychology to enhance...
Yunu Partnership with WCG and IgniteData Transforms Clinical Trial Imaging
In the dynamic world of clinical trials, Yunu is revolutionizing imaging services with cutting-edge technology and strategic partnerships. Jeffrey...
How to Improve Clinical Trials by Empowering the Patient to Share their RWD and Patient-Contributed Data
In the rapidly evolving world of clinical trial technology, Debi Willis, CEO of MyPatientLink, is leading the charge in...
Transforming Clinical Trials: Gen Li’s Vision for the Future
In the dynamic world of clinical trials, Gen Li of Phesi offers a unique perspective on the industry’s challenges...
Advancing Cancer Treatment with Nektar Therapeutics: Insights into NKTR-255
In this interview, we sit down with Mario Marcondes from Nektar Therapeutics to explore the advancements and potential of...
Eisai’s Innovative Bayesian Approach Accelerates Alzheimer’s Drug Approval
At the DPHARM conference, Eisai Inc. showcased their groundbreaking use of Bayesian methods to achieve accelerated approval for their...
Transforming Clinical Trials: ActiGraph’s Strategic Acquisition
In this conversation with Christine Guo, Chief Scientific Officer at ActiGraph, we explored the impact of Actigraph’s acquisition of...